1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics

Chronic Disease Analysis & Statistics

1-15 of 15 reports

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 88 pages

Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Fibrodysplasia ...

  • World
  • South Africa
  • Drug Development
  • Musculoskeletal Disorder
  • Industry analysis
  • Pharmaceutical Registrations
  • Smoking Prevalence

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021

  • $ 2000
  • December 2021
  • 75 pages

Hyperphosphatemia In Chronic Kidney Disease (Nutritional Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney ...

  • World
  • China
  • Chronic Disease
  • Drug Development
  • Industry analysis
  • Patients Undergoing Dialysis
  • Drug Approval

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021

  • $ 3500
  • December 2021
  • 90 pages

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drugs In Development, 2021 Summary Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma ...

  • World
  • Pharmaceutical
  • Cancer
  • Industry analysis

Hypertension (Cardiovascular) - Drugs in Development, 2021

  • $ 2500
  • November 2021
  • 872 pages

Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provides an overview of the ...

  • World
  • Hypertension
  • Cardiology
  • Industry analysis

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021

  • $ 2000
  • November 2021
  • 170 pages

Anemia in Chronic Kidney Disease (Renal Anemia) (Hematology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease - Drugs ...

  • World
  • Japan
  • Chronic Disease
  • Blood Disease
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021

  • $ 2000
  • November 2021
  • 274 pages

Sicca Syndrome (Sjogren) (Immunology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Sicca Syndrome - Drugs In Development, 2021, provides an overview ...

  • World
  • Japan
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 218 pages

Diabetic Foot Ulcers (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers - Drugs In Development, 2021, provides ...

  • United States
  • South Africa
  • Type 2 Diabetes
  • Drug Development
  • Industry analysis
  • Drug Approval
  • Medical Technology Density

Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 424 pages

Diabetic Retinopathy (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy - Drugs In Development, 2021, provides ...

  • United States
  • Type 2 Diabetes
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2500
  • October 2021
  • 857 pages

Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes - Drugs In Development, 2021, ...

  • World
  • Type 1 Diabetes
  • Endocrine Disease
  • Industry analysis

Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2500
  • October 2021
  • 1416 pages

Type 2 Diabetes (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Drugs In Development, 2021, provides an overview ...

  • World
  • Type 2 Diabetes
  • Endocrine Disease
  • Industry analysis

Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 329 pages

Hypercholesterolemia (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia - Drugs In Development, 2021, provides ...

  • World
  • China
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 123 pages

Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Heterozygous familial hype ...

  • World
  • China
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 156 pages

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Drugs In Development, 2021, provides an ...

  • China
  • Jiangsu
  • Musculoskeletal Disorder
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021

  • $ 2000
  • October 2021
  • 86 pages

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synovitis - Drugs In Development, ...

  • World
  • Drug Development
  • Musculoskeletal Disorder
  • Industry analysis
  • Pharmaceutical Registrations
  • Drug Approval

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021

  • $ 3500
  • October 2021
  • 58 pages

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021 Summary According to the recently published report ’Insulin Like Growth Factor I - Drugs In ...

  • World
  • Therapy
  • Biopharmaceutical
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Drug Approval


About 400 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Peru Economic Analysis

  • January 2022
  • 26 pages
  • Peru
  • Pathology
  • Healthcare
  • Country analysis
  • Labour Force
  • Years Of Schooling

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on